Srra stock quote

Get breaking news and analysis on Sierra Oncology, Inc. (SRRA) stock, price quote and chart, trading and investing tools. Get breaking news and analysis on Sierra Oncology, Inc. (SRRA) stock SRRA Sierra Oncology, Inc. Stock Quote - FINVIZ.com Sierra Oncology, Inc., a clinical stage drug development company, is advancing targeted therapeutics for the treatment of patients with unmet medical needs in hematology and oncology.

Find the latest Sierra Oncology, Inc. (SRRA) stock quote, history, news and other vital information to help you with your stock trading and investing. SRRA Stock Price | Sierra Oncology Inc. Stock Quote (U.S ... Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of patients with cancer. It engages in the business of researching, developing, and commercializing therapies for the treatment of patients with cancer. SRRA - Sierra Oncology Inc Stock quote - CNNMoney.com Find real-time SRRA - Sierra Oncology Inc stock quotes, company profile, news and forecasts from CNN Business. Pronai Therapeutics, Inc. - SRRA - Stock Price Today - Zacks Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month.

SRRA's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low

SRRA - Stock quote for SIERRA ONCOLOGY, INC. - MSN Money View the latest SRRA stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of SIERRA ONCOLOGY, INC.. SRRA - Sierra Oncology, Inc. Summary, Stock Quote and News ... Jan 01, 2010 · Sierra Oncology Inc is a clinical-stage drug development company. It focuses on the research, development, and commercialization of DNA Damage Response (DDR) therapeutics for … SRRA | Sierra Oncology Inc. Analyst Estimates | MarketWatch

Get Sierra Oncology Inc (SRRA:NASDAQ) real-time stock quotes, news and financial information from CNBC.

SRRA - Sierra Oncology Stock Price - Barchart.com It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. SRRA Stock Price Quote & News - Sierra Oncology | Robinhood View the real-time SRRA price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Sierra Oncology against related stocks people have also bought like ONTX, NTEC, NIO, and TTNP. 1,021 people own Sierra Oncology on Robinhood on April 2, 2020. SRRA Stock Price and Chart — NASDAQ:SRRA — TradingView

Sierra Oncology Completes Conversion Of Preferred To Common Stock And Issues Stock To Gilead. By PR Newswire. Feb 6, 2020 7:00 AM EST. PRESS RELEASES. Sierra Oncology Announces Reverse Stock …

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of patients with cancer. It engages in the business of researching, developing, and commercializing therapies for the treatment of patients with cancer.

Sierra Oncology Inc. advanced stock charts by MarketWatch. View SRRA historial stock data and compare to other stocks and exchanges.

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month.

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of patients with cancer. It engages in the business of researching, developing, and commercializing therapies for the treatment of patients with cancer. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.